Myo-inositol supplementation in gestational diabetes mellitus: is there any interference with diet?

ABSTRACT:

Background/objectives

Gestational Diabetes Mellitus (GDM) affects 31.6% of pregnant women in Qatar. Myo-inositol (MI) supplementation has been proposed to reduce GDM risk, but its interaction with diet and lifestyle remains unclear. This study assessed the effects of physical activity and diet on MI supplementation and GDM onset throughout pregnancy.

Subjects/methods

A randomized double-blind clinical trial was conducted at Sidra Medicine hospital, involving pregnant women assigned to either the MI (n = 31) or placebo (PLA, n = 33) arm. The Oral Glucose Tolerance Test (OGTT) was conducted between 24 and 28 weeks of gestation. Dietary intake was assessed using 24-h dietary recall and Food Frequency Questionnaires (FFQ), and physical activity and lifestyle data w

SUBMITTER: Ahmed SH 

PROVIDER: S-EPMC12504215 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature